Clinical trial NCT06810297: Effect of a Therapeutic Exercise and an Education Program on Sexual Function and Experience in People With Endometriosis
Official title: Effect of a Therapeutic Exercise and an Education Program on Sexual Function and Experience in People With Endometriosis
Study type: INTERVENTIONAL
Overall status: ENROLLING_BY_INVITATION
Phase: NA
Conditions: Endometriosis
Sexual Function
Sex Behavior
Keywords: Endometriosis
Sexual Function
Sexual Experience
Lead sponsor: University of Valencia
Sponsor class: OTHER
First posted: 2025-02-05
Enrollment: 28
Sex: FEMALE
Minimum age (years): 18
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: This is a randomized clinical trial that will be carried out in people with endometriosis divided into two groups: the experimental group (EG) that will receive therapeutic exercise combine with sexual education, and the control group (CG) who will receive the therapeutic exercise program.

The participants will be evaluated at three moments: before starting the study (T1), after the 8-week treatment program (T2) and after 4 weeks of follow-up in which they will be encouraged to continue with the treatment (T3). Objective and subjective data of the participants will be evaluated. T1 will be assessed with a sociodemographic questionnaire and the FSFI and MSSCQ surveys. T2 and T3 will assess blood pressure, heart rate, variability of the autonomic system, the ability to dissociate the lumbopelvic movement from the thoracolumbar, measurement of the muscles of the transverse, internal and external obliques, the distance between the rectus abdominis and the pelvic floor, subjective perception of effort during exercise and subjective perception of orgasmic intensity.


Eligibility criteria: Inclusion Criteria:

* People of legal age (over 18 years old)
* Not older than 50 years old
* Currently residing in Spain
* Spanish speakers
* With a medical diagnosis of endometriosis
* Without any other associated gynecological pathology

Exclusion Criteria:

* Minors
* People over 50 years old
* Those with cognitive limitations that prevent them from completing the different questionnaires used
* People who are involved in litigation processes
* People with gynecological pathologies other than endometriosis

Primary outcomes:
measure: Quality of Life - Sexual Function
timeFrame: Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program).
measure: Quality of Life - Sexual self-concept
timeFrame: Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program).
Secondary outcomes:
measure: Quality of Life - Pleasure
timeFrame: Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program).
measure: Physical-Funcionality - Motor control
timeFrame: Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program).
measure: Physical-Funcionality- Pelvic floor and abdominal ultrasound
timeFrame: Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program).
Other outcomes:
measure: Excitation
timeFrame: Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program).
measure: Excitation
timeFrame: Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program).
measure: Excitation
timeFrame: Measurements will be taken prior to the intervention (week 0 of the program), after the intervention has ended (week 8 of the program) and one month after the intervention has ended (week 12 of the program).
Locations:
city: Valencia
country: Spain
facility: Laura Fuentes Aparicio
city: Valencia
country: Spain
facility: University of Valencia
Study officials:
References: